https://apnews.com/article/2022-midterm-elections-walker-warnock-runoff-3d4e4d1ab1760792454e1cbd618ce332
Mirum Pharmaceuticals Announces New PDUFA Date Of March 13, 2024 For LIVMARLI For The Treatment Of Cholestatic Pruritus In Progressive Familial Intrahepatic Cholestasis
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) today announced that the U.S. Food and Drug Administration (FDA) has extended the review of the Supplemental New Drug Application (sNDA) for LIVMARLI® (maralixibat) oral
